April 16, 2024
2 min watch
Save
VIDEO: Lindstrom highlights two dry eye treatments from Surface Ophthalmics
Issue: May 25, 2024
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Richard L. Lindstrom, MD, overviews two dry eye products from Surface Ophthalmics.
One is an over-the-counter artificial tear targeted for surgery-associated dry eye syndrome, and the other is a mycophenolate-based immunosuppressive indicated for mild to moderate dry eye, with positive results seen in a phase 2 trial.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Lindstrom reports being the chairman of the board at Surface Ophthalmics.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.